CORE--PHARMACY

核心--药房

• 批准号: 6445488
• 负责人: DARRYL GRENDAHL
• 金额: $ 7.23万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-04-04 至 2002-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6445488
• 关键词: biomedical facility; drug adverse effect; neoplasm /cancer; oncology; oncology nursing; pharmacy

The Mayo Clinic Cancer Center Pharmacy Shared Resource provides comprehensive pharmacy and nursing services in support of approximately 100 active cancer clinical trials. It provides procurement, storage, and accountability of investigational agents. In addition, administration of cytotoxic chemotherapy, growth factors, immunomodulatory agents, antiemetics, and supportive care medication is provided. Special expertise with both investigational and commercially available cancer therapeutic agents resides in the Cancer Center Pharmacy Shared Resource, ensuring a uniformly high standard of safe and accurate treatment for all Mayo Clinic cancer patients.

梅奥诊所癌症中心药房共享资源提供全面的药房和护理服务，支持大约 100 项正在进行的癌症临床试验。 它提供研究代理的采购、存储和问责。 此外，还提供细胞毒性化疗、生长因子、免疫调节剂、止吐剂和支持性护理药物的施用。 癌症中心药房共享资源拥有研究性和市售癌症治疗药物的特殊专业知识，确保为所有 Mayo Clinic 癌症患者提供统一高标准的安全、准确的治疗。